WASATCH ADVISORS INC 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-07 2:15 pm Sale |
2025-03-31 | 13G | Esperion Therapeutics, Inc. ESPR |
WASATCH ADVISORS INC | 10,931,257 5.500% |
-4,232,629 (-27.91%) |
Filing |
| 2024-02-09 4:14 pm Purchase |
2024-02-09 | 13G | Esperion Therapeutics, Inc. ESPR |
WASATCH ADVISORS INC | 15,163,886 12.600% |
5,362,725 (+54.72%) |
Filing |
| 2023-02-10 1:46 pm Purchase |
2023-02-10 | 13G | Esperion Therapeutics, Inc. ESPR |
WASATCH ADVISORS INC | 9,801,161 12.800% |
462,115 (+4.95%) |
Filing |
| 2022-02-11 2:54 pm Purchase |
2022-02-11 | 13G | Esperion Therapeutics, Inc. ESPR |
WASATCH ADVISORS INC | 9,339,046 14.400% |
5,341,036 (+133.59%) |
Filing |
| 2021-02-09 2:56 pm Purchase |
2021-02-09 | 13G | Esperion Therapeutics, Inc. ESPR |
WASATCH ADVISORS INC | 3,998,010 14.300% |
161,567 (+4.21%) |
Filing |
| 2020-12-03 2:36 pm Purchase |
2020-12-03 | 13G | Esperion Therapeutics, Inc. ESPR |
WASATCH ADVISORS INC | 3,836,443 13.800% |
3,836,443 (New Position) |
Filing |